Page last updated: 2024-10-14

xct790

Description

XCT790: structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID6918788
CHEMBL ID189753
CHEBI ID79999
MeSH IDM0470192

Synonyms (55)

Synonym
gtpl2832
(e)-3-[4-[[2, 4-bis(trifluoromethyl)phenyl]methoxy]-3-methoxyphenyl]-2-cyano-n-[5- (trifluoromethyl)-1,3,4-thiadiazol-2-yl]prop-2-enamide
xct-790
xct790, >=98% (hplc), solid
725247-18-7
xct 790
BCB03_000874
NCGC00165952-01
xct790
NCGC00165952-02
BRD-K00044672-001-01-8
bdbm50155833
3-[4-(2,4-bis-trifluoromethyl-benzyloxy)-3-methoxy-phenyl]-2-cyano-n-(5-trifluoromethyl-[1,3,4]thiadiazol-2-yl)-acrylamide
CHEMBL189753 ,
chebi:79999 ,
(e)-3-[4-[[2,4-bis(trifluoromethyl)phenyl]methoxy]-3-methoxyphenyl]-2-cyano-n-[5-(trifluoromethyl)-1,3,4-thiadiazol-2-yl]prop-2-enamide
HMS3263N08
3-[4-(2,4-bis-trifluoromethylbenzyloxy)-3-methoxyphenyl]-2-cyano-n-(5-trifluoromethyl-1,3,4-thiadiazol-2-yl)acrylamide
LP01263
FD5021
CCG-222567
HY-10426
tox21_501263
NCGC00261948-01
AC-33712
3-(4-(2,4-bis(trifluoromethyl)benzyloxy)-3-methoxyphenyl)-2-cyano-n-(5-(trifluoromethyl)-1,3,4-thiadiazol-2-yl)acrylamide
AKOS024457878
mfcd08277031
796844-24-1
3-(4-{[2,4-bis(trifluoromethyl)phenyl]methoxy}-3-methoxyphenyl)-2-cyano-n-[5-(trifluoromethyl)-1,3,4-thiadiazol-2-yl]prop-2-enamide
NCGC00165952-04
NCGC00165952-07
NCGC00165952-03
BCP08393
EX-A1708
Q8041720
SDCCGSBI-0633819.P001
NCGC00165952-08
AMY40919
(e)-3-(4-((2,4-bis(trifluoromethyl)benzyl)oxy)-3-methoxyphenyl)-2-cyano-n-(5-(trifluoromethyl)-1,3,4-thiadiazol-2-yl)acrylamide
3-(4-((2,4-bis(trifluoromethyl)benzyl)oxy)-3-methoxyphenyl)-2-cyano-n-(5-(trifluoromethyl)-1,3,4-thiadiazol-2-yl)acrylamide
AS-55852
S0407
AKOS037644991
A899925
hqfnfoogglsbbt-awnivkpzsa-n
(2e)-3-[4-[[2,4-bis(trifluoromethyl)phenyl]methoxy]-3-methoxyphenyl]-2-cyano-n-[5-(trifluoromethyl)-1,3,4-thiadiazol-2-yl]-2-propenamide
2-propenamide, 3-[4-[[2,4-bis(trifluoromethyl)phenyl]methoxy]-3-methoxyphenyl]-2-cyano-n-[5-(trifluoromethyl)-1,3,4-thiadiazol-2-yl]-, (2e)-
3-(4-((2,4-bis(trifluoromethyl)benzyl)oxy)-3-methoxyphenyl)-2-cyano-n-(5-trifluoromethyl-(1,3,4)thiadiazol-2-yl)acrylamide
a4ce428lgj ,
3-(4-((2,4-bis(trifluoromethyl)phenyl)methoxy)-3-methoxyphenyl)-2-cyano-n-(5-(trifluoromethyl)-1,3,4-thiadiazol-2-yl)-2-propenamide
2-propenamide, 3-(4-((2,4-bis(trifluoromethyl)phenyl)methoxy)-3-methoxyphenyl)-2-cyano-n-(5-(trifluoromethyl)-1,3,4-thiadiazol-2-yl)-
unii-a4ce428lgj
2-propenamide, 3-(4-((2,4-bis(trifluoromethyl)phenyl)methoxy)-3-methoxyphenyl)-2-cyano-n-(5-(trifluoromethyl)-1,3,4-thiadiazol-2-yl)-, (2e)-
(2e)-3-(4-((2,4-bis(trifluoromethyl)phenyl)methoxy)-3-methoxyphenyl)-2-cyano-n-(5-(trifluoromethyl)-1,3,4-thiadiazol-2-yl)-2-propenamide

Actions

ExcerptReference
"XCT790 was found to cause cell cycle arrest at the mitotic phase."( Antitumor effect of XCT790, an ERRα inverse agonist, on ERα-negative endometrial cancer cells.
Kataoka, H; Kitawaki, J; Kokabu, T; Matsushima, H; Mori, T; Tarumi, Y; Yoriki, K, 2019
)

Treatment

ExcerptReference
"XCT790 treatment also increased ERK phosphorylation in C2C12, whereas ERRα overexpression decreased early ERK activation, consistent with the opposing effects of these treatments on differentiation."( Estrogen-related receptor α regulates skeletal myocyte differentiation via modulation of the ERK MAP kinase pathway.
Huss, JM; Murray, J, 2011
)

Toxicity

ExcerptReference
"Aggrephagy is a selective autophagic degradation intracellular mechanism that clears toxic misfolded protein aggregates such as α-synuclein."( XCT 790 is a pharmacological aggrephagy inducer in a yeast model of proteotoxicity.
Jayaprakash Rao, M; Manjithaya, R; Suresh, SN, 2021
)

Bioavailability

ExcerptReference
" Preliminary pharmacokinetic studies suggested that it possessed a good pharmacokinetic profile with an oral bioavailability of 71."( 1-Phenyl-4-benzoyl-1H-1,2,3-triazoles as orally bioavailable transcriptional function suppressors of estrogen-related receptor α.
Ding, K; Duan, L; Liu, Y; Pan, X; Ren, X; Xu, S; Zhang, L; Zhang, Z; Zhuang, X, 2013
)
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
cinnamamidesAn enamide which is cinnamamide or a derivative of cinnamamide obtained by replacement of one or more of its hydrogens.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (25)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
thioredoxin reductaseRattus norvegicus (Norway rat)Potency12.65110.100020.879379.4328AID588453; AID588456
phosphopantetheinyl transferaseBacillus subtilisPotency14.12540.141337.9142100.0000AID1490
USP1 protein, partialHomo sapiens (human)Potency50.11870.031637.5844354.8130AID504865
DNA polymerase III, partialBacillus subtilisPotency10.62131.062114.152826.6795AID485295
regulator of G-protein signaling 4Homo sapiens (human)Potency18.88760.531815.435837.6858AID504845
estrogen-related nuclear receptor alphaHomo sapiens (human)Potency5.70750.001530.607315,848.9004AID1224819; AID1224820; AID1224821
ParkinHomo sapiens (human)Potency29.09290.819914.830644.6684AID720572
euchromatic histone-lysine N-methyltransferase 2Homo sapiens (human)Potency8.43680.035520.977089.1251AID504332
heat shock 70kDa protein 5 (glucose-regulated protein, 78kDa)Homo sapiens (human)Potency52.11940.016525.307841.3999AID602332
NPC intracellular cholesterol transporter 1 precursorHomo sapiens (human)Potency58.04790.01262.451825.0177AID485313
D(1A) dopamine receptorHomo sapiens (human)Potency2.59280.02245.944922.3872AID488982
atrial natriuretic peptide receptor 1 precursorHomo sapiens (human)Potency23.93410.134610.395030.1313AID1347049
vitamin D3 receptor isoform VDRAHomo sapiens (human)Potency26.83340.354828.065989.1251AID504847
chromobox protein homolog 1Homo sapiens (human)Potency89.12510.006026.168889.1251AID488953
atrial natriuretic peptide receptor 2 precursorHomo sapiens (human)Potency16.48160.00669.809418.4927AID1347050
flap endonuclease 1Homo sapiens (human)Potency6.70160.133725.412989.1251AID588795
ubiquitin carboxyl-terminal hydrolase 2 isoform aHomo sapiens (human)Potency16.48160.65619.452025.1189AID463106
ras-related protein Rab-9AHomo sapiens (human)Potency91.99970.00022.621531.4954AID485297
peptidyl-prolyl cis-trans isomerase NIMA-interacting 1Homo sapiens (human)Potency23.93410.425612.059128.1838AID504536
DNA polymerase kappa isoform 1Homo sapiens (human)Potency20.14460.031622.3146100.0000AID588579
histone acetyltransferase KAT2A isoform 1Homo sapiens (human)Potency8.42790.251215.843239.8107AID504327
Ataxin-2Homo sapiens (human)Potency7.07950.011912.222168.7989AID588378
phosphoglycerate kinaseTrypanosoma brucei brucei TREU927Potency37.93300.07578.474229.0628AID504547
ATP-dependent phosphofructokinaseTrypanosoma brucei brucei TREU927Potency37.93300.060110.745337.9330AID485368
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Steroid hormone receptor ERR1Homo sapiens (human)IC50 (µMol)0.30190.00201.16639.6400AID1507652; AID1509383; AID1509384; AID241429; AID569736; AID748012
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (10)

Processvia Protein(s)Taxonomy
regulation of DNA-templated transcriptionSteroid hormone receptor ERR1Homo sapiens (human)
positive regulation of transcription by RNA polymerase IISteroid hormone receptor ERR1Homo sapiens (human)
intracellular steroid hormone receptor signaling pathwaySteroid hormone receptor ERR1Homo sapiens (human)
regulation of transcription by RNA polymerase IISteroid hormone receptor ERR1Homo sapiens (human)
negative regulation of receptor internalizationAtaxin-2Homo sapiens (human)
regulation of translationAtaxin-2Homo sapiens (human)
RNA metabolic processAtaxin-2Homo sapiens (human)
P-body assemblyAtaxin-2Homo sapiens (human)
stress granule assemblyAtaxin-2Homo sapiens (human)
RNA transportAtaxin-2Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (14)

Processvia Protein(s)Taxonomy
DNA-binding transcription factor activity, RNA polymerase II-specificSteroid hormone receptor ERR1Homo sapiens (human)
DNA-binding transcription factor activitySteroid hormone receptor ERR1Homo sapiens (human)
nuclear steroid receptor activitySteroid hormone receptor ERR1Homo sapiens (human)
steroid bindingSteroid hormone receptor ERR1Homo sapiens (human)
protein bindingSteroid hormone receptor ERR1Homo sapiens (human)
zinc ion bindingSteroid hormone receptor ERR1Homo sapiens (human)
protein domain specific bindingSteroid hormone receptor ERR1Homo sapiens (human)
sequence-specific DNA bindingSteroid hormone receptor ERR1Homo sapiens (human)
sequence-specific double-stranded DNA bindingSteroid hormone receptor ERR1Homo sapiens (human)
estrogen response element bindingSteroid hormone receptor ERR1Homo sapiens (human)
nuclear receptor activitySteroid hormone receptor ERR1Homo sapiens (human)
RNA bindingAtaxin-2Homo sapiens (human)
epidermal growth factor receptor bindingAtaxin-2Homo sapiens (human)
protein bindingAtaxin-2Homo sapiens (human)
mRNA bindingAtaxin-2Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (14)

Processvia Protein(s)Taxonomy
fibrillar centerSteroid hormone receptor ERR1Homo sapiens (human)
nucleusSteroid hormone receptor ERR1Homo sapiens (human)
nucleoplasmSteroid hormone receptor ERR1Homo sapiens (human)
cytoplasmSteroid hormone receptor ERR1Homo sapiens (human)
microtubule cytoskeletonSteroid hormone receptor ERR1Homo sapiens (human)
intercellular bridgeSteroid hormone receptor ERR1Homo sapiens (human)
chromatinSteroid hormone receptor ERR1Homo sapiens (human)
nucleusSteroid hormone receptor ERR1Homo sapiens (human)
cytoplasmAtaxin-2Homo sapiens (human)
Golgi apparatusAtaxin-2Homo sapiens (human)
trans-Golgi networkAtaxin-2Homo sapiens (human)
cytosolAtaxin-2Homo sapiens (human)
cytoplasmic stress granuleAtaxin-2Homo sapiens (human)
membraneAtaxin-2Homo sapiens (human)
perinuclear region of cytoplasmAtaxin-2Homo sapiens (human)
ribonucleoprotein complexAtaxin-2Homo sapiens (human)
cytoplasmic stress granuleAtaxin-2Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (44)

Assay IDTitleYearJournalArticle
AID1347152Confirmatory screen NINDS AMC qHTS for Zika virus inhibitors2020Proceedings of the National Academy of Sciences of the United States of America, 12-08, Volume: 117, Issue:49
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
AID504810Antagonists of the Thyroid Stimulating Hormone Receptor: HTS campaign2010Endocrinology, Jul, Volume: 151, Issue:7
A small molecule inverse agonist for the human thyroid-stimulating hormone receptor.
AID1347161Confirmatory screen NINDS Rhodamine qHTS for Zika virus inhibitors2020Proceedings of the National Academy of Sciences of the United States of America, 12-08, Volume: 117, Issue:49
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
AID1347086qHTS for Inhibitors of the Functional Ribonucleoprotein Complex (vRNP) of Lymphocytic Choriomeningitis Arenaviruses (LCMV): LCMV Primary Screen - GLuc reporter signal2020Antiviral research, 01, Volume: 173A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity.
AID504812Inverse Agonists of the Thyroid Stimulating Hormone Receptor: HTS campaign2010Endocrinology, Jul, Volume: 151, Issue:7
A small molecule inverse agonist for the human thyroid-stimulating hormone receptor.
AID1347050Natriuretic polypeptide receptor (hNpr2) antagonism - Pilot subtype selectivity assay2019Science translational medicine, 07-10, Volume: 11, Issue:500
Inhibition of natriuretic peptide receptor 1 reduces itch in mice.
AID1347059CD47-SIRPalpha protein protein interaction - Alpha assay qHTS validation2019PloS one, , Volume: 14, Issue:7
Quantitative high-throughput screening assays for the discovery and development of SIRPα-CD47 interaction inhibitors.
AID504836Inducers of the Endoplasmic Reticulum Stress Response (ERSR) in human glioma: Validation2002The Journal of biological chemistry, Apr-19, Volume: 277, Issue:16
Sustained ER Ca2+ depletion suppresses protein synthesis and induces activation-enhanced cell death in mast cells.
AID1347049Natriuretic polypeptide receptor (hNpr1) antagonism - Pilot screen2019Science translational medicine, 07-10, Volume: 11, Issue:500
Inhibition of natriuretic peptide receptor 1 reduces itch in mice.
AID1347153Confirmatory screen GU AMC qHTS for Zika virus inhibitors2020Proceedings of the National Academy of Sciences of the United States of America, 12-08, Volume: 117, Issue:49
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
AID1347151Optimization of GU AMC qHTS for Zika virus inhibitors: Unlinked NS2B-NS3 protease assay2020Proceedings of the National Academy of Sciences of the United States of America, 12-08, Volume: 117, Issue:49
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
AID1347405qHTS to identify inhibitors of the type 1 interferon - major histocompatibility complex class I in skeletal muscle: primary screen against the NCATS LOPAC collection2020ACS chemical biology, 07-17, Volume: 15, Issue:7
High-Throughput Screening to Identify Inhibitors of the Type I Interferon-Major Histocompatibility Complex Class I Pathway in Skeletal Muscle.
AID1347410qHTS for inhibitors of adenylyl cyclases using a fission yeast platform: a pilot screen against the NCATS LOPAC library2019Cellular signalling, 08, Volume: 60A fission yeast platform for heterologous expression of mammalian adenylyl cyclases and high throughput screening.
AID1347167Vero cells viability qHTS for Zika virus inhibitors2020Proceedings of the National Academy of Sciences of the United States of America, 12-08, Volume: 117, Issue:49
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
AID588349qHTS for Inhibitors of ATXN expression: Validation of Cytotoxic Assay
AID1347057CD47-SIRPalpha protein protein interaction - LANCE assay qHTS validation2019PloS one, , Volume: 14, Issue:7
Quantitative high-throughput screening assays for the discovery and development of SIRPα-CD47 interaction inhibitors.
AID588378qHTS for Inhibitors of ATXN expression: Validation
AID1347083qHTS for Inhibitors of the Functional Ribonucleoprotein Complex (vRNP) of Lassa (LASV) Arenavirus: Viability assay - alamar blue signal for LASV Primary Screen2020Antiviral research, 01, Volume: 173A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity.
AID1347058CD47-SIRPalpha protein protein interaction - HTRF assay qHTS validation2019PloS one, , Volume: 14, Issue:7
Quantitative high-throughput screening assays for the discovery and development of SIRPα-CD47 interaction inhibitors.
AID1508630Primary qHTS for small molecule stabilizers of the endoplasmic reticulum resident proteome: Secreted ER Calcium Modulated Protein (SERCaMP) assay2021Cell reports, 04-27, Volume: 35, Issue:4
A target-agnostic screen identifies approved drugs to stabilize the endoplasmic reticulum-resident proteome.
AID1347082qHTS for Inhibitors of the Functional Ribonucleoprotein Complex (vRNP) of Lassa (LASV) Arenavirus: LASV Primary Screen - GLuc reporter signal2020Antiviral research, 01, Volume: 173A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity.
AID1347045Natriuretic polypeptide receptor (hNpr1) antagonism - Pilot counterscreen GloSensor control cell line2019Science translational medicine, 07-10, Volume: 11, Issue:500
Inhibition of natriuretic peptide receptor 1 reduces itch in mice.
AID1347168HepG2 cells viability qHTS for Zika virus inhibitors2020Proceedings of the National Academy of Sciences of the United States of America, 12-08, Volume: 117, Issue:49
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
AID1347149Furin counterscreen qHTS for Zika virus inhibitors2020Proceedings of the National Academy of Sciences of the United States of America, 12-08, Volume: 117, Issue:49
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
AID1347169Tertiary RLuc qRT-PCR qHTS assay for Zika virus inhibitors2020Proceedings of the National Academy of Sciences of the United States of America, 12-08, Volume: 117, Issue:49
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
AID1347163384 well plate NINDS AMC confirmatory qHTS for Zika virus inhibitors2020Proceedings of the National Academy of Sciences of the United States of America, 12-08, Volume: 117, Issue:49
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
AID1509384Binding affinity to GST-tagged ERRalpha-LBD (unknown origin) using fluorescein-conjugated coactivator PGC-1alpha incubated for 1 hr by TR-FRET assay2019ACS medicinal chemistry letters, May-09, Volume: 10, Issue:5
Identification of New Small-Molecule Inducers of Estrogen-related Receptor α (ERRα) Degradation.
AID748012Inverse agonist activity at GAL4-fused ERRalpha (unknown origin) transfected in african green monkey CV1 cells after 24 hrs by luciferase reporter gene assay2013Journal of medicinal chemistry, Jun-13, Volume: 56, Issue:11
1-Phenyl-4-benzoyl-1H-1,2,3-triazoles as orally bioavailable transcriptional function suppressors of estrogen-related receptor α.
AID1509383Inverse agonist activity at CMX-gal4-fused ERRgamma (unknown origin) transfected in (African Green monkey CV1 cells incubated for 20 hrs by luciferase reporter gene assay2019ACS medicinal chemistry letters, May-09, Volume: 10, Issue:5
Identification of New Small-Molecule Inducers of Estrogen-related Receptor α (ERRα) Degradation.
AID243558Percent inhibition of estrogen-related receptor alpha Gal4 activity at 10 uM2004Journal of medicinal chemistry, Nov-04, Volume: 47, Issue:23
Identification of a selective inverse agonist for the orphan nuclear receptor estrogen-related receptor alpha.
AID1507652Inverse agonist activity at GAL4-DNA binding domain-fused human ERRalpha ligand binding domain expressed in HEK293 cells assessed as inhibition of transcriptional activity after 48 hrs by luciferase reporter gene assay2017European journal of medicinal chemistry, Aug-18, Volume: 136The discovery of novel, potent ERR-alpha inverse agonists for the treatment of triple negative breast cancer.
AID748035Inverse agonist activity at GAL4-fused ERRalpha (unknown origin) transfected in african green monkey CV1 cells at 1 uM after 24 hrs by luciferase reporter gene assay relative to control2013Journal of medicinal chemistry, Jun-13, Volume: 56, Issue:11
1-Phenyl-4-benzoyl-1H-1,2,3-triazoles as orally bioavailable transcriptional function suppressors of estrogen-related receptor α.
AID241429Inhibition of estrogen-related receptor alpha Gal4 activity2004Journal of medicinal chemistry, Nov-04, Volume: 47, Issue:23
Identification of a selective inverse agonist for the orphan nuclear receptor estrogen-related receptor alpha.
AID569736Antagonist activity at ERRalpha LBD expressed in HEK293 cells assessed as Gal4-SRC2 interaction by two hybrid luciferase reporter gene assay2011Journal of medicinal chemistry, Feb-10, Volume: 54, Issue:3
Identification of diaryl ether-based ligands for estrogen-related receptor α as potential antidiabetic agents.
AID1347411qHTS to identify inhibitors of the type 1 interferon - major histocompatibility complex class I in skeletal muscle: primary screen against the NCATS Mechanism Interrogation Plate v5.0 (MIPE) Libary2020ACS chemical biology, 07-17, Volume: 15, Issue:7
High-Throughput Screening to Identify Inhibitors of the Type I Interferon-Major Histocompatibility Complex Class I Pathway in Skeletal Muscle.
AID1347164384 well plate NINDS Rhodamine confirmatory qHTS for Zika virus inhibitors2020Proceedings of the National Academy of Sciences of the United States of America, 12-08, Volume: 117, Issue:49
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
AID1347172Secondary qRT-PCR qHTS assay for selected Zika virus inhibitors2020Proceedings of the National Academy of Sciences of the United States of America, 12-08, Volume: 117, Issue:49
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
AID1347171Orthogonal mCherry assay for qRT-PCR qHTS of selected Zika virus inhibitors2020Proceedings of the National Academy of Sciences of the United States of America, 12-08, Volume: 117, Issue:49
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
AID1347170Vero cells viability counterscreen for qRT-PCR qHTS assay of selected Zika virus inhibitors2020Proceedings of the National Academy of Sciences of the United States of America, 12-08, Volume: 117, Issue:49
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
AID1347156DAPI mCherry counterscreen qHTS for Zika virus inhibitors2020Proceedings of the National Academy of Sciences of the United States of America, 12-08, Volume: 117, Issue:49
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
AID1347158ZIKV-mCherry secondary qHTS for Zika virus inhibitors2020Proceedings of the National Academy of Sciences of the United States of America, 12-08, Volume: 117, Issue:49
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
AID1346840Human Estrogen-related receptor-alpha (3B. Estrogen-related receptors)2004Proceedings of the National Academy of Sciences of the United States of America, Jun-15, Volume: 101, Issue:24
Regulation of PPARgamma coactivator 1alpha (PGC-1alpha) signaling by an estrogen-related receptor alpha (ERRalpha) ligand.
AID1794808Fluorescence-based screening to identify small molecule inhibitors of Plasmodium falciparum apicoplast DNA polymerase (Pf-apPOL).2014Journal of biomolecular screening, Jul, Volume: 19, Issue:6
A High-Throughput Assay to Identify Inhibitors of the Apicoplast DNA Polymerase from Plasmodium falciparum.
AID1794808Fluorescence-based screening to identify small molecule inhibitors of Plasmodium falciparum apicoplast DNA polymerase (Pf-apPOL).
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (61)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's11 (18.03)29.6817
2010's37 (60.66)24.3611
2020's13 (21.31)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other61 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]